SFRP2 and neoplasm: Furthermore, several studies consider abnormal methylation of SFRP2 as a noninvasive diagnostic and prognostic biomarker of CRC [13–15], suggesting that SFRP2 might be implicated in cancer development, but also as a tumor suppressor gene.